GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DexTech Medical AB (XSAT:DEX) » Definitions » Earnings Yield (Joel Greenblatt) %

DexTech Medical AB (XSAT:DEX) Earnings Yield (Joel Greenblatt) % : -5.87% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is DexTech Medical AB Earnings Yield (Joel Greenblatt) %?

DexTech Medical AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr89.08 Mil. DexTech Medical AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-5.22 Mil. DexTech Medical AB's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2024 was -5.87%.

The historical rank and industry rank for DexTech Medical AB's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

XSAT:DEX' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -27.41   Med: -1.67   Max: -0.43
Current: -9.88

During the past 11 years, the highest Earnings Yield (Joel Greenblatt) of DexTech Medical AB was -0.43%. The lowest was -27.41%. And the median was -1.67%.

XSAT:DEX's Earnings Yield (Joel Greenblatt) % is ranked better than
59.09% of 1391 companies
in the Biotechnology industry
Industry Median: -16.37 vs XSAT:DEX: -9.88

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. DexTech Medical AB's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


DexTech Medical AB Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for DexTech Medical AB's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexTech Medical AB Earnings Yield (Joel Greenblatt) % Chart

DexTech Medical AB Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.73 -1.06 -1.16 -9.82 -8.53

DexTech Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.59 -8.53 -9.23 -10.62 -5.87

Competitive Comparison of DexTech Medical AB's Earnings Yield (Joel Greenblatt) %

For the Biotechnology subindustry, DexTech Medical AB's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexTech Medical AB's Earnings Yield (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where DexTech Medical AB's Earnings Yield (Joel Greenblatt) % falls into.



DexTech Medical AB Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

DexTech Medical ABs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jun. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-4.939/57.95055
=-8.52 %

DexTech Medical AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-5.22 Mil.



DexTech Medical AB  (XSAT:DEX) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


DexTech Medical AB Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of DexTech Medical AB's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


DexTech Medical AB (XSAT:DEX) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB develops candidate medications with applications within urological oncology, for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases. The company has a strong clinical base with valuable specialist expertise from research laboratories and manufacturing to clinical oncology.

DexTech Medical AB (XSAT:DEX) Headlines